Nathan Bays

Executive Director at Valo

Nathan Bays has a diverse range of work experience in the biotechnology and pharmaceutical industries. Nathan has held various roles at different companies, starting with Exelixis, Inc. where they worked as a Research Scientist. At Exelixis, they were involved in chemical biology research.

Nathan then joined Merck, where they served as a Senior Research Biochemist, Research Fellow, Team Lead, and Principal Scientist. During their tenure at Merck, Nathan led multiple programs and focused on high throughput flow cytometry and lead identification/optimization.

After their time at Merck, Nathan worked at Eli Lilly and Company as a Research Advisor. In this role, they designed and implemented discovery and data analysis platforms for oncology drug discovery, specifically immuno-oncology.

Following Eli Lilly, they joined Ginkgo Bioworks, Inc., where they had several roles. Nathan first served as a Senior Test Engineer, then as a Test Group Lead for HTS and Assay Development, and finally as the Mammalian Cell Engineering Lead. Nathan was excited to join the synthetic biology revolution at Ginkgo and contributed to the automation and design of CAR-T constructs.

Nathan's next position was at TARA Biosystems, where they worked as a Senior Director of Assay Technologies. Nathan was impressed with TARA's platform for modeling cardiac function using iPSC-derived cardiomyocytes and saw the potential of generating valuable data.

Currently, Nathan works at Valo as the Senior Director of Data and Assay Technologies. Nathan aims to advance their passions for data, drug discovery, and engineering biology. Nathan believes in using data as the true fuel for the drug discovery engine.

Overall, Nathan Bays brings extensive experience in assay technologies, automation, data analysis, and lead optimization to their current role. Their work spans various domains, including oncology, synthetic biology, and cardiac modeling.

Nathan Bays has a Bachelor of Science degree in Molecular Biology from The University of Texas at Austin. Nathan is currently pursuing a Masters degree in Statistics and Biology from Texas A&M University, although the completion date is unknown. Additionally, Nathan has completed a Ph.D. in Biology from UC San Diego, although the specific years of their education at each institution are not provided.

Links

Previous companies

Exelixis logo
Merck logo
Ginkgo Bioworks logo

Timeline

  • Executive Director

    April 1, 2023 - present

  • Senior Director, Data And Assay Technologies

    April, 2022